The trajectory of Sildenafil presents a challenging picture for shareholders. While the initial launch generated substantial returns, the lapse of its exclusive rights opened the door to generic versions, dramatically https://zakariawdpt781590.theblogfairy.com/40580994/sildenafil-and-the-pharmaceutical-industry-a-precarious-bet